Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M41,422Revenue $M15,259Net Margin (%)13.2Z-Score3.3
Enterprise Value $M46,961EPS $3.7Operating Margin %17.5F-Score5
P/E(ttm))21.0Cash Flow Per Share $5.6Pre-tax Margin (%)16.7Higher ROA y-yN
Price/Book4.810-y EBITDA Growth Rate %12.1Quick Ratio1.0Cash flow > EarningsY
Price/Sales2.75-y EBITDA Growth Rate %6.5Current Ratio1.7Lower Leverage y-yN
Price/Cash Flow11.7y-y EBITDA Growth Rate %-1.2ROA % (ttm)7.8Higher Current Ratio y-yN
Dividend Yield %2.6Insider Buy (3m)0ROE % (ttm)23.8Less Shares Outstanding y-yY
Payout Ratio %53.0Shares Outstanding M543ROI % (ttm)15.1Gross Margin Increase y-yN

Gurus Latest Trades with BAX

Number of guru portfolios checked: 56.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
BAXCharles Brandes 2014-03-31 Buy 0.19%$66.49 - $72.85
($68.75)
$ 76.3411%New holding, 204560 sh.204,560
BAXScott Black 2014-03-31 Add0.17%$66.49 - $72.85
($68.75)
$ 76.3411%Add 13.41%179,629
BAXDavid Dreman 2014-03-31 Buy 0.01%$66.49 - $72.85
($68.77)
$ 76.3411%New holding, 2453 sh.2,453
BAXJean-Marie Eveillard 2014-03-31 Reduce$66.49 - $72.85
($68.77)
$ 76.3411%Reduce -85.53%1,100
BAXJohn Hussman 2014-03-31 Reduce-0.49%$66.49 - $72.85
($68.75)
$ 76.3411%Reduce -93.07%7,450
BAXVanguard Health Care Fund 2014-03-31 Reduce-0.41%$66.49 - $72.85
($68.75)
$ 76.3411%Reduce -77.96%531,100
BAXRay Dalio 2014-03-31 Reduce-0.07%$66.49 - $72.85
($68.77)
$ 76.3411%Reduce -67%62,263
BAXScott Black 2013-12-31 Add1.06%$63.89 - $69.47
($66.75)
$ 76.3414%Add 776.11%158,392
BAXJohn Hussman 2013-12-31 Reduce-0.54%$63.89 - $69.47
($66.75)
$ 76.3414%Reduce -58.26%107,450
BAXJean-Marie Eveillard 2013-12-31 Reduce-0.26%$63.89 - $69.47
($66.75)
$ 76.3414%Reduce -99.44%7,600
BAXJames Barrow 2013-12-31 Sold Out -0.22%$63.89 - $69.47
($66.75)
$ 76.3414%Sold Out0
BAXVanguard Health Care Fund 2013-12-31 Reduce-0.17%$63.89 - $69.47
($66.75)
$ 76.3414%Reduce -24.2%2,410,000
BAXRay Dalio 2013-12-31 Reduce-0.03%$63.89 - $69.47
($66.75)
$ 76.3414%Reduce -24.85%188,663
BAXRay Dalio 2013-09-30 Add0.11%$66.35 - $74.43
($71.58)
$ 76.347%Add 339.84%251,063
BAXJames Barrow 2013-09-30 Reduce-0.17%$66.35 - $74.43
($71.58)
$ 76.347%Reduce -41.52%2,076,268
BAXJean-Marie Eveillard 2013-06-30 Add0.06%$68.1 - $73.04
($70.51)
$ 76.348%Add 29.32%1,144,312
BAXRay Dalio 2013-06-30 Buy 0.04%$68.1 - $73.04
($70.51)
$ 76.348%New holding, 57080 sh.57,080
BAXJames Barrow 2013-06-30 Reduce-1.93%$68.1 - $73.04
($70.51)
$ 76.348%Reduce -80.33%3,550,586
BAXJohn Hussman 2013-06-30 Reduce-0.52%$68.1 - $73.04
($70.51)
$ 76.348%Reduce -43.71%254,950
BAXJohn Hussman 2013-03-31 Add1.2%$66.42 - $72.64
($68.58)
$ 76.3411%Add 25782.9%452,950
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

BAX is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
BAX David Dreman 2014-03-312,45300.01New Buy
BAX Charles Brandes 2014-03-31204,5600.040.19New Buy
BAX Scott Black 2014-03-31179,6290.031.4+13.41%
BAX Dodge & Cox 2014-03-313,40400+0.65%
BAX Tweedy Browne 2014-03-312,601,8480.484.4
BAX Mario Gabelli 2014-03-31225,5000.040.09-1.03%
BAX Ray Dalio 2014-03-3162,2630.010.04-67%
BAX Vanguard Health Care Fund 2014-03-31531,1000.10.11-77.96%
BAX Jean-Marie Eveillard 2014-03-311,10000-85.53%
BAX John Hussman 2014-03-317,45000.04-93.07%
BAX Meridian Funds 2013-06-308,60000.02
Premium Most recent portfolio changes are included for Premium Members only!


BAX: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Shapazian Carole JDirector 2014-07-25Sell1,645$76.98-0.83view
STALLKAMP THOMAS TDirector 2014-07-24Sell8,300$76.82-0.62view
HANTSON LUDWIGCorporate Vice President 2014-07-09Sell24,693$760.45view
STROUCKEN ALBERT P LDirector 2014-05-27Sell3,840$74.412.59view
Shapazian Carole JDirector 2014-05-02Sell5,680$75.281.41view
STORM KEES JDirector 2014-04-23Sell5,760$72.455.37view
Devitt Blake EDirector 2014-04-21Sell4,334$73.124.4view
Bufalino Sebastian JCorporate Vice President 2014-03-27Sell21,600$75.11.65view
Shapazian Carole JDirector 2013-09-12Sell1,941$71.586.65view
PARKINSON ROBERT L JRChairman of the Board & CEO 2013-08-01Sell725,750$73.334.1view

Press Releases about BAX :

Quarterly/Annual Reports about BAX:

News about BAX:

Articles On GuruFocus.com
Diamond Hill Capital Comments on Baxter International Inc Jul 25 2014 
Why I Bought Baxter International Jun 19 2014 
Becton, Dickinson and Co. (BDX) Dividend Stock Analysis May 30 2014 
Two Stocks On My Watch List For June 2014 May 29 2014 
Companies That Are Raising Dividends May 16 2014 
Auxier Asset Management's Auxier Report - First Quarter 2014 May 06 2014 
4 Top Stocks in the Medical Device Sector Apr 11 2014 
We Are Confident About Baxter's Plan to Create Two Separate Health Care Companies Mar 28 2014 
Diamond Hill Capital Comments on Baxter International Jan 15 2014 
Diamond Hill Capital Large Cap Fund Q3 Commentary Jan 15 2014 

More From Other Websites
BAX, WLP And COV, 3 Health Services Stocks Pushing The Industry Lower Jul 25 2014
New Lifetime High Today: Baxter International (BAX) Jul 23 2014
Baxter Declares Quarterly Dividend Jul 22 2014
Baxter Declares Quarterly Dividend Jul 22 2014
Why Baxter Is A Fine Dividend Growth Idea Jul 18 2014
Gambro acquisition boosts Baxter's sales Jul 17 2014
UPDATE 1-Medical products boost Baxter's sales Jul 17 2014
Baxter International Tops Earnings Ests but Shrinks Guidance Jul 17 2014
Baxter Q2 Earnings Beat Estimates, But Guidance Soft Jul 17 2014
Baxter Exceeds Expectations in Second Quarter with Strong Growth across Global Franchises Jul 17 2014
Baxter says 'feels good' about guidance Jul 17 2014
Baxter International Inc Earnings Call scheduled for 8:30 am ET today Jul 17 2014
BAXTER INTERNATIONAL INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Results of... Jul 17 2014
Q2 2014 Baxter International Inc. Earnings Release - Before Market Open Jul 17 2014
Baxter Exceeds Expectations in Second Quarter with Strong Growth across Global Franchises Jul 17 2014
Will Baxter International (BAX) Surprise this Earnings? Jul 16 2014
Tax Reform, Not Tax Inversions, Will Rescue The U.S. Pharma, Bio, And Medical-Device Industries Jul 15 2014

Add Notes, Comments or Ask Questions

User Comments

Sww
ReplySww - 4 weeks ago
Bax medical devices revenue ~9b, bio science ~7b
using 3X sales of medical devices company and 4X for drugs company, 27b+28b = 55b market cap,as of June 2014, BAX market cap is 39b, so it can sell for

72 * (1 + 16/39) = 99

72 is current stock price, with an upside of around 35%

so my guess is BAX may be able to sell for around 90 after spin-off.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK
Email Hide